Showing results (931-940 of 977) with videos related to

Sort By:
Pageof 98
Journal for Immunotherapy of Cancer|November 17, 2020
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBCChiara Massa, Thomas Karn, Carsten Denkert, et al.
Circulation|November 12, 2019
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort AnalysisAmbarish Pandey, Kershaw V Patel, Wanpen Vongpatanasin, et al.
Scientific Reports|February 9, 2020
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cellsNicola Mitwasi, Anja Feldmann, Claudia Arndt, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Journal of Synchrotron Radiation|September 3, 2021
Performance and characterization of the FinEstBeAMS beamline at the MAX IV LaboratoryKirill Chernenko, Antti Kivimäki, Rainer Pärna, et al.
NPJ Digital Medicine|February 6, 2025
Real world federated learning with a knowledge distilled transformer for cardiac CT imagingMalte Tölle, Philipp Garthe, Clemens Scherer, et al.
Future Science OA|February 7, 2020
Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitisAyse L Mindikoglu, Cristian Coarfa, Antone R Opekun, et al.
JAMA Network Open|October 29, 2020
Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass IndexRohan Khera, Ambarish Pandey, Colby R Ayers, et al.
American Journal of Obstetrics and Gynecology|April 22, 2022
Maternal and neonatal outcomes of pregnancies with COVID-19 after medically assisted reproduction: results from the prospective COVID-19-Related Obstetrical and Neonatal Outcome StudyYvonne Ziert, Michael Abou-Dakn, Clara Backes, et al.
Cancer Research|June 29, 2017
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ SignalingMarco Donia, Katja Harbst, Marit van Buuren, et al.
Pageof 98